Industry: Medical Devices & Consumables
Published Date: 2025-03-10
Pages: 126 Pages
Report ld: 4614420
Request Sample
Customized Report
Muscle-on-a-Chip Market Size(US$)

CAGR 2025-2031
26.1%
Market Size,2031
USD 1,445
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Muscle-on-a-Chip was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
As an emerging market segment in the biomedical field, the muscle chip market has gradually attracted widespread attention from the industry in recent years. Muscle chips can simulate the structure and function of muscle tissue, providing a powerful tool for the research of muscle-related diseases, drug development and personalized medicine. Muscle chips have broad application potential in multiple fields, including diagnosis of muscle diseases, drug screening, toxicity testing, sports rehabilitation, and personalized medicine. By simulating the physiological and pathological processes of muscle tissue, muscle chips can help researchers gain a deeper understanding of the pathogenesis of muscle diseases, accelerate drug development, and improve treatment effects. Overall, the muscle chip market has broad development prospects and huge market potential.
This report aims to provide a comprehensive presentation of the global market for Muscle-on-a-Chip, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Muscle-on-a-Chip by region & country, by Type, and by Application.
The Muscle-on-a-Chip market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Muscle-on-a-Chip.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Muscle-on-a-Chip manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Muscle-on-a-Chip in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Muscle-on-a-Chip in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Muscle-on-a-Chip Product Introduction
1.2 Global Muscle-on-a-Chip Market Size Forecast
1.2.1 Global Muscle-on-a-Chip Sales Value (2020-2031)
1.2.2 Global Muscle-on-a-Chip Sales Volume (2020-2031)
1.2.3 Global Muscle-on-a-Chip Sales Price (2020-2031)
1.3 Muscle-on-a-Chip Market Trends & Drivers
1.3.1 Muscle-on-a-Chip Industry Trends
1.3.2 Muscle-on-a-Chip Market Drivers & Opportunity
1.3.3 Muscle-on-a-Chip Market Challenges
1.3.4 Muscle-on-a-Chip Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Muscle-on-a-Chip Players Revenue Ranking (2024)
2.2 Global Muscle-on-a-Chip Revenue by Company (2020-2025)
2.3 Global Muscle-on-a-Chip Players Sales Volume Ranking (2024)
2.4 Global Muscle-on-a-Chip Sales Volume by Company Players (2020-2025)
2.5 Global Muscle-on-a-Chip Average Price by Company (2020-2025)
2.6 Key Manufacturers Muscle-on-a-Chip Manufacturing Base and Headquarters
2.7 Key Manufacturers Muscle-on-a-Chip Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Muscle-on-a-Chip
2.9 Muscle-on-a-Chip Market Competitive Analysis
2.9.1 Muscle-on-a-Chip Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Muscle-on-a-Chip Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscle-on-a-Chip as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Skeletal Muscle
3.1.2 Smooth Muscle
3.1.3 Other
3.2 Global Muscle-on-a-Chip Sales Value by Type
3.2.1 Global Muscle-on-a-Chip Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Muscle-on-a-Chip Sales Value, by Type (2020-2031)
3.2.3 Global Muscle-on-a-Chip Sales Value, by Type (%) (2020-2031)
3.3 Global Muscle-on-a-Chip Sales Volume by Type
3.3.1 Global Muscle-on-a-Chip Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Muscle-on-a-Chip Sales Volume, by Type (2020-2031)
3.3.3 Global Muscle-on-a-Chip Sales Volume, by Type (%) (2020-2031)
3.4 Global Muscle-on-a-Chip Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical R&D
4.1.2 Sports Medicine
4.1.3 Sports Equipment Development
4.2 Global Muscle-on-a-Chip Sales Value by Application
4.2.1 Global Muscle-on-a-Chip Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Muscle-on-a-Chip Sales Value, by Application (2020-2031)
4.2.3 Global Muscle-on-a-Chip Sales Value, by Application (%) (2020-2031)
4.3 Global Muscle-on-a-Chip Sales Volume by Application
4.3.1 Global Muscle-on-a-Chip Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Muscle-on-a-Chip Sales Volume, by Application (2020-2031)
4.3.3 Global Muscle-on-a-Chip Sales Volume, by Application (%) (2020-2031)
4.4 Global Muscle-on-a-Chip Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Muscle-on-a-Chip Sales Value by Region
5.1.1 Global Muscle-on-a-Chip Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Muscle-on-a-Chip Sales Value by Region (2020-2025)
5.1.3 Global Muscle-on-a-Chip Sales Value by Region (2026-2031)
5.1.4 Global Muscle-on-a-Chip Sales Value by Region (%), (2020-2031)
5.2 Global Muscle-on-a-Chip Sales Volume by Region
5.2.1 Global Muscle-on-a-Chip Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Muscle-on-a-Chip Sales Volume by Region (2020-2025)
5.2.3 Global Muscle-on-a-Chip Sales Volume by Region (2026-2031)
5.2.4 Global Muscle-on-a-Chip Sales Volume by Region (%), (2020-2031)
5.3 Global Muscle-on-a-Chip Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Muscle-on-a-Chip Sales Value, 2020-2031
5.4.2 North America Muscle-on-a-Chip Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Muscle-on-a-Chip Sales Value, 2020-2031
5.5.2 Europe Muscle-on-a-Chip Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Muscle-on-a-Chip Sales Value, 2020-2031
5.6.2 Asia Pacific Muscle-on-a-Chip Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Muscle-on-a-Chip Sales Value, 2020-2031
5.7.2 South America Muscle-on-a-Chip Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Muscle-on-a-Chip Sales Value, 2020-2031
5.8.2 Middle East & Africa Muscle-on-a-Chip Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Muscle-on-a-Chip Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Muscle-on-a-Chip Sales Value and Sales Volume
6.2.1 Key Countries/Regions Muscle-on-a-Chip Sales Value, 2020-2031
6.2.2 Key Countries/Regions Muscle-on-a-Chip Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Muscle-on-a-Chip Sales Value, 2020-2031
6.3.2 United States Muscle-on-a-Chip Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Muscle-on-a-Chip Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Muscle-on-a-Chip Sales Value, 2020-2031
6.4.2 Europe Muscle-on-a-Chip Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Muscle-on-a-Chip Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Muscle-on-a-Chip Sales Value, 2020-2031
6.5.2 China Muscle-on-a-Chip Sales Value by Type (%), 2024 VS 2031
6.5.3 China Muscle-on-a-Chip Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Muscle-on-a-Chip Sales Value, 2020-2031
6.6.2 Japan Muscle-on-a-Chip Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Muscle-on-a-Chip Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Muscle-on-a-Chip Sales Value, 2020-2031
6.7.2 South Korea Muscle-on-a-Chip Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Muscle-on-a-Chip Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Muscle-on-a-Chip Sales Value, 2020-2031
6.8.2 Southeast Asia Muscle-on-a-Chip Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Muscle-on-a-Chip Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Muscle-on-a-Chip Sales Value, 2020-2031
6.9.2 India Muscle-on-a-Chip Sales Value by Type (%), 2024 VS 2031
6.9.3 India Muscle-on-a-Chip Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Emulate
7.1.1 Emulate Company Information
7.1.2 Emulate Introduction and Business Overview
7.1.3 Emulate Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Emulate Muscle-on-a-Chip Product Offerings
7.1.5 Emulate Recent Development
7.2 CN Bio
7.2.1 CN Bio Company Information
7.2.2 CN Bio Introduction and Business Overview
7.2.3 CN Bio Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 CN Bio Muscle-on-a-Chip Product Offerings
7.2.5 CN Bio Recent Development
7.3 TissUse
7.3.1 TissUse Company Information
7.3.2 TissUse Introduction and Business Overview
7.3.3 TissUse Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 TissUse Muscle-on-a-Chip Product Offerings
7.3.5 TissUse Recent Development
7.4 Axion Biosystems
7.4.1 Axion Biosystems Company Information
7.4.2 Axion Biosystems Introduction and Business Overview
7.4.3 Axion Biosystems Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Axion Biosystems Muscle-on-a-Chip Product Offerings
7.4.5 Axion Biosystems Recent Development
7.5 Nortis
7.5.1 Nortis Company Information
7.5.2 Nortis Introduction and Business Overview
7.5.3 Nortis Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Nortis Muscle-on-a-Chip Product Offerings
7.5.5 Nortis Recent Development
7.6 BioIVT
7.6.1 BioIVT Company Information
7.6.2 BioIVT Introduction and Business Overview
7.6.3 BioIVT Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 BioIVT Muscle-on-a-Chip Product Offerings
7.6.5 BioIVT Recent Development
7.7 InSphero
7.7.1 InSphero Company Information
7.7.2 InSphero Introduction and Business Overview
7.7.3 InSphero Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 InSphero Muscle-on-a-Chip Product Offerings
7.7.5 InSphero Recent Development
7.8 Mimetas
7.8.1 Mimetas Company Information
7.8.2 Mimetas Introduction and Business Overview
7.8.3 Mimetas Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Mimetas Muscle-on-a-Chip Product Offerings
7.8.5 Mimetas Recent Development
7.9 Ascendance Biotechnology
7.9.1 Ascendance Biotechnology Company Information
7.9.2 Ascendance Biotechnology Introduction and Business Overview
7.9.3 Ascendance Biotechnology Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Ascendance Biotechnology Muscle-on-a-Chip Product Offerings
7.9.5 Ascendance Biotechnology Recent Development
7.10 StemoniX
7.10.1 StemoniX Company Information
7.10.2 StemoniX Introduction and Business Overview
7.10.3 StemoniX Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 StemoniX Muscle-on-a-Chip Product Offerings
7.10.5 StemoniX Recent Development
7.11 Tara Biosystems
7.11.1 Tara Biosystems Company Information
7.11.2 Tara Biosystems Introduction and Business Overview
7.11.3 Tara Biosystems Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Tara Biosystems Muscle-on-a-Chip Product Offerings
7.11.5 Tara Biosystems Recent Development
7.12 BGI Genomics
7.12.1 BGI Genomics Company Information
7.12.2 BGI Genomics Introduction and Business Overview
7.12.3 BGI Genomics Muscle-on-a-Chip Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 BGI Genomics Muscle-on-a-Chip Product Offerings
7.12.5 BGI Genomics Recent Development
8 Industry Chain Analysis
8.1 Muscle-on-a-Chip Industrial Chain
8.2 Muscle-on-a-Chip Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Muscle-on-a-Chip Sales Model
8.5.2 Sales Channel
8.5.3 Muscle-on-a-Chip Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Muscle-on-a-Chip market is projected to grow from US$ 359 million in 2025 to US$ 1784 million by 2032, at a CAGR of 26.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-31
Pages: 167
USD 4900.00
(Single User License)
The global Muscle-on-a-Chip market size was US$ 359 million in 2025 and is forecast to reach a readjusted size of US$ 1784 million by 2032 with a CAGR of 26.1% during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 92
USD 4250.00
(Single User License)
The global market for Muscle-on-a-Chip was estimated to be worth US$ 359 million in 2025 and is projected to reach US$ 1784 million, growing at a CAGR of 26.1% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 112
USD 3950.00
(Single User License)
The global Muscle-on-a-Chip market was valued at US$ 359 million in 2025 and is anticipated to reach US$ 1784 million by 2032, at a CAGR of 26.1% from 2026 to 2032.
Published Date: 2026-01-15
Pages: 124
USD 2900.00
(Single User License)
The global Muscle-on-a-Chip market is projected to grow from US$ 291 million in 2024 to US$ 1445 million by 2031, at a CAGR of 26.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 166
USD 4900.00
(Single User License)
The global Muscle-on-a-Chip market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 92
USD 4250.00
(Single User License)
The global market for Muscle-on-a-Chip was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 1445 million by 2031, growing at a CAGR of 26.1% during the forecast period.
Published Date: 2025-03-10
Pages: 94
USD 2900.00
(Single User License)
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published Date: 2024-04-28
Pages: 97
USD 2900.00
(Single User License)
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published Date: 2024-04-28
Pages: 113
USD 3950.00
(Single User License)
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published Date: 2024-04-28
Pages: 122
USD 4350.00
(Single User License)
The global Muscle-on-a-Chip market is projected to grow from US$ 359 million in 2025 to US$ 1784 million by 2032, at a CAGR of 26.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-31
Pages: 167
The global Muscle-on-a-Chip market size was US$ 359 million in 2025 and is forecast to reach a readjusted size of US$ 1784 million by 2032 with a CAGR of 26.1% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 92
The global market for Muscle-on-a-Chip was estimated to be worth US$ 359 million in 2025 and is projected to reach US$ 1784 million, growing at a CAGR of 26.1% from 2026 to 2032.
Published: 2026-01-19
Pages: 112
The global Muscle-on-a-Chip market was valued at US$ 359 million in 2025 and is anticipated to reach US$ 1784 million by 2032, at a CAGR of 26.1% from 2026 to 2032.
Published: 2026-01-15
Pages: 124
The global Muscle-on-a-Chip market is projected to grow from US$ 291 million in 2024 to US$ 1445 million by 2031, at a CAGR of 26.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 166
The global Muscle-on-a-Chip market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 92
The global market for Muscle-on-a-Chip was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 1445 million by 2031, growing at a CAGR of 26.1% during the forecast period.
Published: 2025-03-10
Pages: 94
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published: 2024-04-28
Pages: 97
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published: 2024-04-28
Pages: 113
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published: 2024-04-28
Pages: 122
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now